The unified social credit code/registration number of Wuxi Kaifu Pharmaceutical Co., Ltd. Liyang Branch is 91320481573821420W, and the enterprise is in the opening state.
The business scope of Wuxi Kaifu Pharmaceutical Co., Ltd. Liyang Branch is: the production of raw materials (sodium aescinate and sodium pantothenate), the research and development of biomedical technology, and consulting services. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Jiangsu Province, the total registered capital of companies with similar business scope is1651520,000 yuan, and the main capital is concentrated in 23 enterprises with a scale of more than 50 million. Within the scope of this province, the registered capital of mobile enterprises belongs to the general.
See more information and materials of Liyang Branch of Wuxi Kaifu Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.